Search Results For ''

  • Gold and Silver rallies prompt investor to load up on Bronze

    Having watched many Olympic Games over the year, investor Hugh Honey is confident that Bronze will be the next commodity to boom following recent rallies in Gold and Silver prices.  So confident is Honey, he has taken out various loans to hire storage spaces and filled them with the metal having stockpiled Bronze while it

    Read More
    Public
  • Hand sanitiser: WA Government engages Matrix for solar-powered smart dispensers

    Even once we’re all vaccinated, the mass adoption of hand sanitiser availability is likely to stay for a while with Matrix Composites & Engineering (ASX: MCE) engaged by the West Australian Government to develop solar-powered bulk dispensers for public use.  The $1.5 million contract will see Matrix produce two prototypes for the bulk dispensers which

    Read More
    Public
  • Cosmetics distributer seeks $6m IPO to launch own brand of EZZ skincare

    Australian skincare company, EZZ Life Science Holdings Limited (Prospective ASX: EZZ), are the latest small cap looking to list on the exchange this month after a strong FY20 for the company. EZZ life is looking to raise $6M at an offer price of $0.50 per share, giving the company an indicative market capitalisation of $19M

    Read More
    Public
  • Pandemic focus on living better sends Healthia’s earnings skyward

    Vowing to look after themselves better in the wake of a pandemic, Australians are keenly focused on their personal health and wellness as evidenced by allied healthcare services provider Healthia (ASX: HLA) which is expected to report more than an 86% increase in earnings.  A market update was provided by Healthia which operates a network

    Read More
    Public
  • Paradigm eyes FDA and TGA submission as patient data confirms major joint pain reduction

    Clinical data trials being conducted by Paradigm Biopharmaceuticals (ASX: PAR) continue to deliver impressive patient outcomes for sufferers of chronic joint pain and osteoarthritis with 13 new patients having joined the trials and reported significantly better quality of life upon treatment with Zilosul. The most recent round of trials have been conducted in Australia under

    Read More
    Public
  • Should investors succumb to the BNPL FOMO?

    As with the coronavirus, the buy now pay later (BNPL) sector was expected to have fizzled out by now. Instead, it’s stepped up another level in terms of revenue usage trends and valuations. Among investors, Fear of Missing Out (FOMO) is rife as the BNPL contagion continues to displace the role of credit cards in

    Read More
    Public